's Avatar

@id-kieran.bsky.social

34 Followers  |  50 Following  |  53 Posts  |  Joined: 13.01.2025  |  2.0954

Latest posts by id-kieran.bsky.social on Bluesky

#pitt_idfall25

10.11.2025 15:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

10.11.2025 15:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

04.11.2025 03:08 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

04.11.2025 03:07 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

27.10.2025 13:40 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

27.10.2025 13:39 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

20.10.2025 20:26 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

20.10.2025 20:25 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

14.10.2025 13:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

14.10.2025 13:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_IDfall25

12.10.2025 18:08 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

12.10.2025 18:08 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections | Contagion Live Cefiderocol is noninferior to standard of care empiric treatment of noscomial Gram-negative bloodstream infections in open-label "Game-Changer" trial.

Cefiderocol is noninferior to standard of care empiric treatment of noscomial Gram-negative bloodstream infections in open-label "Game-Changer" trial. #IDsky #Medsky

12.10.2025 12:41 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1

#pitt_idfall25

30.09.2025 17:48 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

30.09.2025 17:48 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

22.09.2025 15:44 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

22.09.2025 15:43 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall2025

16.09.2025 14:30 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall2025

16.09.2025 14:29 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

08.09.2025 17:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_idfall25

08.09.2025 17:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_IDfall25

08.09.2025 17:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#pitt_IDfall25

08.09.2025 17:18 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

🚨 Ebola Outbreak in Kasai Province, DRC. 28 suspected cases and 15 deaths, including 4 health-care workers, have been reported. Africa CDC & the WHO are mobilizing rapid response teams, vaccines, & supplies to contain the outbreak. #IDsky #MEDsky

More details: www.contagionlive.com/view/ebola-o...

08.09.2025 16:26 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 2

#pitt_id25

04.09.2025 17:11 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1

#pitt_id25

03.09.2025 15:06 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 1

#putt_id25

03.09.2025 14:55 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Azelastine Nasal Spray Reduces SARS-CoV-2 Infections in Phase 2 Trial Single-center randomized trial shows lower infection rates and extended time to SARS-CoV-2 infection, though larger studies are needed to confirm findings.

Azelastine nasal spray showed promise in a phase 2 trial - patients using it had fewer SARS-CoV-2 infections (2.2% vs 6.7%), longer time to infection, and reduced symptomatic cases. Larger studies are needed to confirm. #COVID19 #IDsky #MEDsky

More details: www.contagionlive.com/view/azelast...

03.09.2025 12:00 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 0    πŸ“Œ 4

#PITT_ID25

21.04.2025 18:43 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#PITT_ID25

21.04.2025 18:43 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@id-kieran is following 20 prominent accounts